Back

Impact of left ventricular ejection fraction on clinical outcomes in females undergoing percutaneous coronary intervention with drug-eluting stents

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Congress committee e-posters choice in aortic and intervention Outcome ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Johny Nicolas

Icahn School of Medicine at Mount Sinai, New York City (United States of America)

32 More presentations in this session

Presentation thumbnail
Predictive value of cardiac troponin increase after percutaneous coronary intervention: is it just a marker of disease complexity?
Doctor B. Chevalier (Massy, FR)
Abstract Slides
Presentation thumbnail
Word of caution on adding hemiarch replacement to a proximal aortic aneurysm repair: long-term outcome analysis of over 1,000 patients
Mr C. Pearsall (New York, US)
Abstract Slides
Presentation thumbnail
Utility of familial screening in non-syndromic thoracic aortic disease
Doctor J. Rodriguez Ortuno (Gijon, ES)
Abstract Slides
Presentation thumbnail
Outcomes of endovascular management of the aorta in connective tissue disorders
Doctor X. Yuan (Milton Keynes, GB)
Abstract Slides
Presentation thumbnail
Cerebral embolic protection devices for stroke prevention in transcatheter aortic valve implantation, a meta-analysis
Mr D. Perez Camargo (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Congress committee e-posters choice in aortic and intervention

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Effects of percutaneous coronary intervention on improvement of left ventricular ejection fraction among chronic coronary syndrome patients with left ventricular systolic dysfunction
thumbnail
Congress Presentation
Percutaneous coronary revascularization timing in patients undergoing transcatheter aortic valve implantation
thumbnail
Congress Presentation
Percutaneous coronary intervention versus optimal medical therapy for chronic total occlusion: an updated meta-analysis of randomized controlled trials comparing clinical and health status outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources